I don't think anyone can provide an example but I'd love to see anybody willing to try & I will make very generous concessions to try and ease an approach.
Any company below $50M MC or what the heck below $100M would still struggle to find a comparative.
> $9M Cash
> 2x Phase II
> FDA / EMA Orphan Drug Designation (even 1 is adequate)
> Big Pharma / Big Biotech partner
Even just two of the above will do
PAB Price at posting:
4.7¢ Sentiment: None Disclosure: Held
